174 related articles for article (PubMed ID: 20417591)
1. Primary invasive oral aspergillosis: an updated literature review.
Fuqua TH; Sittitavornwong S; Knoll M; Said-Al-Naief N
J Oral Maxillofac Surg; 2010 Oct; 68(10):2557-63. PubMed ID: 20417591
[No Abstract] [Full Text] [Related]
2. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Kim MS; Lee HM; Sung HS; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Int J Dermatol; 2012 May; 51(5):621-3. PubMed ID: 21790547
[No Abstract] [Full Text] [Related]
4. Voriconazole versus amphotericin B for invasive aspergillosis.
Blot F; Edé C; Nitenberg GM
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
[No Abstract] [Full Text] [Related]
5. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
6. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
[No Abstract] [Full Text] [Related]
7. Therapy of sinuorbital aspergillosis with amphotericin B colloidal dispersion.
Rieske K; Handrick W; Müller H; Sterker I
Mycoses; 1998; 41(7-8):287-92. PubMed ID: 9861833
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
11. Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Herbrecht R
Ann Hematol; 2002; 81 Suppl 2():S52-3. PubMed ID: 12611078
[No Abstract] [Full Text] [Related]
12. [Acute renal failure induced by amphotericin B during the treatment of invasive aspergillosis in patients with acute myeloblastic leukemia (two case reports and literature review)].
Filatov LB
Ter Arkh; 2003; 75(7):83-6. PubMed ID: 12934490
[No Abstract] [Full Text] [Related]
13. Successful treatment of invasive Aspergillus rhinosinusitis in a child with acute myeloid leukemia.
Jaing TH; Yang CP; Hung IJ; Chiu CH; Hsueh C
J Otolaryngol; 2000 Aug; 29(4):257-9. PubMed ID: 11003082
[No Abstract] [Full Text] [Related]
14. Voriconazole versus amphotericin B for invasive aspergillosis.
Karthaus M
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
[No Abstract] [Full Text] [Related]
15. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
16. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
Ruchlemer R; Yinnon AM; Hershko C
Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of brain aspergillosis with voriconazole.
Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
[TBL] [Abstract][Full Text] [Related]
19. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
[No Abstract] [Full Text] [Related]
20. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
La Nasa G; Littera R; Maccioni A; Ledda A; Vacca A; Contu L
Hematol J; 2004; 5(2):178-80. PubMed ID: 15048069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]